Veba, Viag are in talks on a merger
Article Abstract:
Veba AG and Viag AG are engaged in negotiations over a possible merger. Such a merger could have a value of up to approximately $15 billion (14.26 billion euros). However, the negotiations could collapse at any phase. Veba and Viag are utility concerns based in Germany. The possible merger reflects the trend toward consolidation that is taking place in the European region.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
Diversified Companies, Strategy & planning, Germany, Planning, Abstract, Veba AG, Viag AG
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
A woman's touch at Telia
Article Abstract:
The article is an interview with Marianne Nivert, the new CEO of Telia AB.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
Sweden, Telephone Communication, Executive changes & profiles, Officials and employees, Telia AB, Interview, Nivert, Marianne
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Telecommunications services industry, Telecommunications industry
Similar abstracts:
- Abstracts: Ericsson revamps management amid intensified competition. Telia seeks to buy SBC's 41.6% stake in TeleDanmark
- Abstracts: Telkom, Vodafone in stake-sale talks. PLDT is willing to sell 20% stake in its smart unit. Vodafone is in talks about boosting its stake in SFR
- Abstracts: Tapping India for antibiotics. Powell seeks to assure leaders in India and Pakistan
- Abstracts: Interbrew sells 80% of Blue Jays in $112 million deal. Interbrew takes an 80% stake in Diebels
- Abstracts: U.K. drug maker agrees to buy Transkaryotic. Hedge Funds vex a Shire takeover of Transkaryotic. Marconi will link ipsaris with Easynet in stock deal
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.